Katie Miller, Key Player in Anti-340B ‘Dark Money’ Campaign, Leaves White House Adviser Role

Katie Miller, a key figure in a dark money anti-340B campaign, has left her role as a White House adviser.
A Trump administration adviser and key figure in a dark money effort to tie the 340B program to immigration growth, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Cassidy Says 340B ‘Was Never Meant to be Part of an Earnings Call’

U.S. Sen. Bill Cassidy (R-La.) discussed the 340B program in a recent interview with Punchbowl News.
A key U.S. senator on 340B policy continued to raise concerns this week about the current state of the drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

BI Asks Tennessee Contract Pharmacies to Report Claims Data Ahead of New State Law, BMS Updates Contract Pharmacy Restrictions

Boehringer Ingelheim announced new 340B claims data requirements for Tennessee covered entities.
Tennessee covered entities must now submit claims data for all Boehringer Ingelheim (BI) 340B drugs filled by their in-house pharmacies [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Defends 340B Hospital Drug Purchasing Restrictions Policy, Asks Federal Court to Reject Premier’s Challenge

HHS attorneys recently urged a Washington D.C. federal court to uphold a 2013 HRSA policy and reject Premier's claim that it unlawfully restricts how certain 340B hospitals can purchase initial drug inventory.
The Trump administration this month urged a Washington D.C. federal court to uphold a 2013 Health Resources and Services Administration [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Vermont House Modifies 340B Contract Pharmacy Access and Hospital Reporting Bill, Hospital Advocates Voice Concerns About Changes

Vermont House lawmakers voted Friday to approve an amended contract pharmacy access bill, which includes price caps on some hospitals that has raised concerns from some state health systems.
The Vermont House on Friday approved a 340B contract pharmacy access bill with Senate-backed hospital reporting requirements and a new [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Provider-Drugmaker Lobbying Group Adds Hospital, Drugmaker: Key Thune Staffer Departs for Private Sector

The 340B Working Table has added Boston Medical Center Health System and Takeda Pharmaceuticals America to its list of members.
A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added another major [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Genentech Tightens Contract Pharmacy Restrictions to Require Hospital Claims Data, Targets 340B Drug Redistribution; 340B Lawyer Pushes Back

Genentech updated its contract pharmacy restrictions to impose new claims data submissions and prevent covered entities from shipping 340B drugs to other locations through “alternate distribution models” or other channels.
A California-based drugmaker this week updated its contract pharmacy restrictions to impose new claims data submissions for hospitals and prevent [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

RFK Jr. Tells Senate Panel 340B Program ‘Controversial’ But Important to Rural Hospitals; HHS Releases MFN Targets for Drugmakers

HHS Secretary Robert F. Kennedy Jr. told a Senate subcommittee Tuesday that the 340B program plays an important role for rural hospitals despite being “very controversial."
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. told a U.S. Senate subcommittee Tuesday that the 340B program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry-Backed AIDS Group Targets 340B in New Ad Campaign

ADAP Advocacy, a drug industry funded group, recently released a minute-long ad that argues 340B unduly benefits providers and could be rife with “fraud, waste and abuse.”
A pharmaceutical industry-funded HIV/AIDS advocacy group is taking aim at the 340B program—questioning if it’s “too big to fail”—in a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Mixed Responses So Far to RFK Jr.’s Comments on 340B Program from 340B Provider Groups

340B advocates offered tepid responses to HHS Secretary Robert F. Kennedy Jr.’s first public remarks on the 340B program on Wednesday.
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s first public remarks on the 340B program—which 340B Report broke [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live